BR0209613A - Composição para tratamento de dor em um mamìfero, e, método para redução ou eliminação de probabilidade de viciamento de um analgésico em um hospedeiro - Google Patents
Composição para tratamento de dor em um mamìfero, e, método para redução ou eliminação de probabilidade de viciamento de um analgésico em um hospedeiroInfo
- Publication number
- BR0209613A BR0209613A BR0209613-7A BR0209613A BR0209613A BR 0209613 A BR0209613 A BR 0209613A BR 0209613 A BR0209613 A BR 0209613A BR 0209613 A BR0209613 A BR 0209613A
- Authority
- BR
- Brazil
- Prior art keywords
- eliminating
- reducing
- composition
- likelihood
- addiction
- Prior art date
Links
- 206010012335 Dependence Diseases 0.000 title abstract 3
- 241000124008 Mammalia Species 0.000 title 1
- 230000000202 analgesic effect Effects 0.000 abstract 4
- 239000003445 gaba agent Substances 0.000 abstract 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 abstract 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 abstract 1
- 229920002554 vinyl polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Addiction (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/853,548 US20020187996A1 (en) | 2001-05-14 | 2001-05-14 | Prevention of addiction in pain management |
| PCT/US2002/011072 WO2002091990A2 (en) | 2001-05-14 | 2002-04-08 | Prevention of addiction in pain management |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0209613A true BR0209613A (pt) | 2004-12-07 |
Family
ID=25316324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0209613-7A BR0209613A (pt) | 2001-05-14 | 2002-04-08 | Composição para tratamento de dor em um mamìfero, e, método para redução ou eliminação de probabilidade de viciamento de um analgésico em um hospedeiro |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US20020187996A1 (enExample) |
| EP (1) | EP1392301B1 (enExample) |
| JP (1) | JP2004534029A (enExample) |
| KR (1) | KR20040020054A (enExample) |
| CN (1) | CN100528156C (enExample) |
| AT (1) | ATE473001T1 (enExample) |
| AU (1) | AU2002342533B2 (enExample) |
| BR (1) | BR0209613A (enExample) |
| CA (1) | CA2446639C (enExample) |
| CZ (1) | CZ20033380A3 (enExample) |
| DE (1) | DE60236927D1 (enExample) |
| ES (1) | ES2348637T3 (enExample) |
| HR (1) | HRP20030892A2 (enExample) |
| HU (1) | HUP0402326A3 (enExample) |
| IL (1) | IL158762A0 (enExample) |
| MX (1) | MXPA03010407A (enExample) |
| NO (1) | NO331509B1 (enExample) |
| NZ (1) | NZ529614A (enExample) |
| PL (1) | PL368505A1 (enExample) |
| WO (1) | WO2002091990A2 (enExample) |
| YU (1) | YU89003A (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001281746C1 (en) * | 2000-07-31 | 2010-09-09 | ISTITUTO GENTILI S.r.l. | Fentanyl composition for nasal administration |
| DE10141650C1 (de) | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
| US20050043345A1 (en) * | 2003-08-22 | 2005-02-24 | Pfizer Inc | Pharmaceutical composition for the prevention and treatment of addiction in a mammal |
| US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
| US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
| CN105497896A (zh) * | 2015-03-31 | 2016-04-20 | 苏州大学 | 一种肿瘤耐药的靶点及其应用 |
| JP7720911B2 (ja) | 2020-12-04 | 2025-08-08 | ラボラトリオス シラネス、エセ．ア．デ セ．べ． | 痛みに対するオピオイド鎮痛薬と抗てんかん薬のコーティングされた安定な固体医薬組成物 |
| US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6541520B1 (en) * | 1998-08-05 | 2003-04-01 | Brookhaven Science Associates | Treatment of addiction and addiction-related behavior |
| US6057368A (en) * | 1998-08-05 | 2000-05-02 | Brookhaven Science Associates Llc | Treatment of addiction and addiction-related behavior |
-
2001
- 2001-05-14 US US09/853,548 patent/US20020187996A1/en not_active Abandoned
-
2002
- 2002-04-08 YU YU89003A patent/YU89003A/sh unknown
- 2002-04-08 EP EP02769652A patent/EP1392301B1/en not_active Expired - Lifetime
- 2002-04-08 BR BR0209613-7A patent/BR0209613A/pt not_active IP Right Cessation
- 2002-04-08 NZ NZ529614A patent/NZ529614A/en unknown
- 2002-04-08 ES ES02769652T patent/ES2348637T3/es not_active Expired - Lifetime
- 2002-04-08 AT AT02769652T patent/ATE473001T1/de not_active IP Right Cessation
- 2002-04-08 DE DE60236927T patent/DE60236927D1/de not_active Expired - Lifetime
- 2002-04-08 MX MXPA03010407A patent/MXPA03010407A/es not_active Application Discontinuation
- 2002-04-08 AU AU2002342533A patent/AU2002342533B2/en not_active Ceased
- 2002-04-08 PL PL02368505A patent/PL368505A1/xx not_active Application Discontinuation
- 2002-04-08 IL IL15876202A patent/IL158762A0/xx unknown
- 2002-04-08 JP JP2002588909A patent/JP2004534029A/ja active Pending
- 2002-04-08 WO PCT/US2002/011072 patent/WO2002091990A2/en not_active Ceased
- 2002-04-08 HR HR20030892A patent/HRP20030892A2/xx not_active Application Discontinuation
- 2002-04-08 CN CNB028098277A patent/CN100528156C/zh not_active Expired - Fee Related
- 2002-04-08 KR KR10-2003-7014736A patent/KR20040020054A/ko not_active Withdrawn
- 2002-04-08 CZ CZ20033380A patent/CZ20033380A3/cs unknown
- 2002-04-08 HU HU0402326A patent/HUP0402326A3/hu unknown
- 2002-04-08 CA CA2446639A patent/CA2446639C/en not_active Expired - Fee Related
- 2002-04-18 US US10/124,660 patent/US6939876B2/en not_active Expired - Fee Related
-
2003
- 2003-01-02 US US10/335,800 patent/US20030134868A1/en not_active Abandoned
- 2003-11-13 NO NO20035038A patent/NO331509B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20030892A2 (en) | 2005-08-31 |
| US20020187996A1 (en) | 2002-12-12 |
| CN1531431A (zh) | 2004-09-22 |
| HUP0402326A3 (en) | 2008-04-28 |
| JP2004534029A (ja) | 2004-11-11 |
| EP1392301A4 (en) | 2004-07-14 |
| NZ529614A (en) | 2006-08-31 |
| NO20035038D0 (no) | 2003-11-13 |
| IL158762A0 (en) | 2004-05-12 |
| US6939876B2 (en) | 2005-09-06 |
| US20030134868A1 (en) | 2003-07-17 |
| KR20040020054A (ko) | 2004-03-06 |
| WO2002091990A3 (en) | 2003-03-27 |
| AU2002342533B2 (en) | 2007-07-05 |
| WO2002091990A2 (en) | 2002-11-21 |
| CA2446639C (en) | 2010-11-02 |
| HUP0402326A2 (hu) | 2005-02-28 |
| ES2348637T3 (es) | 2010-12-10 |
| NO331509B1 (no) | 2012-01-16 |
| MXPA03010407A (es) | 2004-05-05 |
| EP1392301A2 (en) | 2004-03-03 |
| EP1392301B1 (en) | 2010-07-07 |
| US20030004176A1 (en) | 2003-01-02 |
| DE60236927D1 (de) | 2010-08-19 |
| PL368505A1 (en) | 2005-04-04 |
| CA2446639A1 (en) | 2002-11-21 |
| CN100528156C (zh) | 2009-08-19 |
| ATE473001T1 (de) | 2010-07-15 |
| CZ20033380A3 (cs) | 2005-03-16 |
| YU89003A (sh) | 2006-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR027234A1 (es) | Derivados de la toxina clostridial y metodos para el tratamiento del dolor | |
| AR049955A1 (es) | Composiciones y metodos para el tratamiento de trastornos metabolicos | |
| BR0212019A (pt) | Formas de dosagem, métodos para o tratamento da dor, métodos de preparação de uma forma de dosagem e métodos para impedir o abuso de uma forma de dosagem | |
| AU2003268144A1 (en) | Transdermal dosage form comprising an active agent and a salt and free-baseform of an antagonist | |
| BR0306919A (pt) | Métodos para reduzir ou suprimir a efetividade adversa da terapia de l-dopa e/ou do agonista da dopamina, e para tratamento moderado de l-dopa, composição para tratamento moderado de l-dopa, método para tratar doença de parkinson e/ou complicações motoras de l-dopa, composição para o tratamento da doença de parkinson, e, métodos para prolongar o tratamento eficaz da doença de parkinson, e para tratar os distúrbios de movimento | |
| CY1107262T1 (el) | Θεραπεια της εξαρτησης στερησης | |
| BR0315573A (pt) | Método para tratar, prevenir, controlar e/ou modificar dor em um paciente e composição farmacêutica | |
| TWI367751B (en) | Pharmaceutical composition comprising rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction | |
| BR0200246A (pt) | Tratamento de combinação para a depressão | |
| BR0201524A (pt) | Tratamento de combinação para ansiedade e depressão | |
| ATE531366T1 (de) | Zusammensetzungen und verfahren zur behandlung, verminderung, verbesserung oder linderung von erkrankungen des hinteren augensegments | |
| BR0209613A (pt) | Composição para tratamento de dor em um mamìfero, e, método para redução ou eliminação de probabilidade de viciamento de um analgésico em um hospedeiro | |
| BR0311903A (pt) | Tratamento para depressão e ansiedade pela combinação de um inibidor de pde iv e um agente antidepressivo ou ansiolìtico | |
| BR0201974A (pt) | Composição farmacêutica para tratamento de alterações do sono | |
| BR0307022A (pt) | Método de tratamento de um paciente que precisa de analgesia | |
| TW200420290A (en) | Methods for the treatment, prevention and management of macular degeneration | |
| BR0211855A (pt) | Medicamento e método para tratamento e melhoria da qualidade restauradora do sono | |
| WO2006002096A3 (en) | Low doses of l-citrulline for treating diseases | |
| BR0315609A (pt) | Método de tratar, prevenir, modificar ou controlar dor e composição farmacêutica | |
| UA81689C2 (ru) | Способ предоперационного лечения послеоперационной боли бупренорфином | |
| BR0111900A (pt) | Uso de um antagonista do receptor do tipo 1 da angiotensina ii, formulação farmacêutica, e, métodos para o tratamento de uma condição de cefaléia vascular e para o tratamento de enxaqueca | |
| WO2008060381A3 (en) | Method for treating pain or opioid dependence using a specific type of non-opioid agent in combination with a selective excitatory-opioid-receptor inactivator | |
| BRPI0514303A (pt) | composição farmacêutica e método para tratar distúrbios neurodegenerativos | |
| WO2023079466A3 (en) | Treatment of sequelae of coronavirus infections | |
| PT1347753E (pt) | Composicao topica e metodo para o tratamento da incontinencia urinaria de stress |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUI DADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE A 10A ANUIDADE. |